2 Biotech Stocks That Could Soar 29% and 165% According to Wall Street's Top Analysts @themotleyfool #stocks $REGN $SNY $VKTX

2 Biotech Stocks That Could Soar 29% and 165% According to Wall Street's Top Analysts @themotleyfool #stocks $REGN $SNY $VKTX

Key PointsRegeneron Pharmaceuticals is highly profitable and raking in free cash flow. Viking Therapeutics has multiple exciting candidates in the pipeline, including its lead GLP-1 candidate. 10 stocks we like better than Regeneron Pharmaceuticals › The healthcare industry has been a remarkable place for investors to build significant portfolio returns through the years. Companies that are providing life-saving medicines, devices, and other pro…